TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment
The Effect of Weekly Text-message Communication on Treatment Completion Among Patients With Latent Tuberculosis Infection: a Randomised Controlled Trial (WelTel LTBI)
1 other identifier
interventional
350
1 country
3
Brief Summary
This study will examine the impact of use of mobile phones and text messaging on adherence to treatment for patients with latent TB infection. Half (50%) of the 350 anticipated study participants will receive weekly text messages inquiring on their health status in relation to their prescribed treatment, while the other half (50%) will not receive weekly text messages at all. Medical adherence will be assessed by monthly blood-work, clinic visits and by interviewing patients at each of these visits. The investigators hypothesis is that enhanced communication with a health care provider, via a structured cell phone SMS text messaging based program (WelTel), will result in a 15% improvement in the proportion of patients who successfully complete their LTBI treatment regimens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Apr 2012
Longer than P75 for early_phase_1
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2012
CompletedFirst Posted
Study publicly available on registry
March 9, 2012
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedOctober 12, 2015
October 1, 2015
4.5 years
March 6, 2012
October 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful completion of LTBI treatment regimens.
Successful treatment completion is defined as taking at least 80% of the doses of INH prescribed within 12 months or at least 80% of RIF prescribed within 6 months.
4 or 9 months
Study Arms (2)
Non-intervention
NO INTERVENTIONParticipants will only receive standard of care
Cell phone intervention arm
EXPERIMENTALUpon consent, participants will be randomly assigned to receive either 1) standard of care (9 months of INH or 4 months of RIF) and weekly SMS text messages via mobile phone or 2) standard of care (9 months of INH or months of RIF) without weekly SMS text messages via mobile phone.
Interventions
Participants in the intervention arm will receive weekly text messages from the TB control clinic asking how they are.
Eligibility Criteria
You may qualify if:
- Are initiating treatment for latent TB infection;
- Are over the age of 18 years old;
- Own a mobile phone or share access mobile phone access with a household member who consents to participate; AND
- Demonstrate sufficient ability to communicate via text messaging in English or have a family member or friend that is able to provide translation and assistance with text messaging for the duration of the study
You may not qualify if:
- Individuals under the age of 18;
- Unable to adequately send and receive text messages for any reason OR
- Enrolled in another clinical trial that may assess or influence treatment adherence.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- British Columbia Cancer Agencycollaborator
Study Sites (3)
New Westminster TB Control Clinic
New Westminster, British Columbia, Canada
Vancouver Downtown TB Control Clinic
Vancouver, British Columbia, Canada
Vancouver TB Control Clinic (VTC),
Vancouver, British Columbia, Canada
Related Publications (3)
El Joueidi S, Bardosh K, Musoke R, Tilahun B, Abo Moslim M, Gourlay K, MacMullin A, Cook VJ, Murray M, Mbaraga G, Nsanzimana S, Lester R. Evaluation of the implementation process of the mobile health platform 'WelTel' in six sites in East Africa and Canada using the modified consolidated framework for implementation research (mCFIR). BMC Med Inform Decis Mak. 2021 Oct 26;21(1):293. doi: 10.1186/s12911-021-01644-1.
PMID: 34702229DERIVEDJohnston JC, van der Kop ML, Smillie K, Ogilvie G, Marra F, Sadatsafavi M, Romanowski K, Budd MA, Hajek J, Cook V, Lester RT. The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial. Eur Respir J. 2018 Feb 7;51(2):1701488. doi: 10.1183/13993003.01488-2017. Print 2018 Feb.
PMID: 29437940DERIVEDvan der Kop ML, Memetovic J, Patel A, Marra F, Sadatsafavi M, Hajek J, Smillie K, Thabane L, Taylor D, Johnston J, Lester RT. The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI). BMJ Open. 2014 Apr 9;4(4):e004362. doi: 10.1136/bmjopen-2013-004362.
PMID: 24719431DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dr. Richard Lester, MD
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2012
First Posted
March 9, 2012
Study Start
April 1, 2012
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
October 12, 2015
Record last verified: 2015-10